PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ciclosporin 0.1% Eye Drops (Verkazia) - Allergic conjunctivitis
PAD Profile : Ciclosporin 0.1% Eye Drops (Verkazia) - Allergic conjunctivitis
Keywords :
severe vernal keratoconjunctivitis, keratitis
Brand Names Include :
Verkazia
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Sodium cromoglicate
- Antazoline
- Azelastine hydrochloride
- Ketotifen fumarate
- Lodoxamide trometamol
- Olopatadine
Other Indications
- Dermatology indications
- Psoriatic arthritis
- Inflammatory bowel disease
- Dry eyes
- Dry eyes
- Neurology indications
- Uveitis
- Renal indications
- Rheumatology indications
- Ocular surface disease
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
02 October 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.
Associated BNF Codes
11. Eye
11.04.02. Other anti-inflammatory preparations